封面
市場調查報告書
商品編碼
1975285

全球血液透析和腹膜透析市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Hemodialysis & Peritoneal Dialysis Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血液透析和腹膜透析市場將從 2025 年的 1,410.6 億美元成長到 2034 年的 3,156 億美元,2026 年至 2034 年的複合年成長率為 9.36%。

由於慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 的盛行率不斷上升,全球血液透析和腹膜透析市場正在擴張。人口老化、糖尿病和高血壓發病率的增加以及文明病是腎衰竭病例的主要促進因素。醫療基礎設施的改善和腎臟替代療法的普及顯著推動了市場需求。

透析設備的科技進步,包括攜帶式和家用透析系統,正在改變患者照護模式。居家透析越來越受歡迎,導致住院率下降,病患生活品質提高。已開發地區優惠的報銷政策和新興經濟體透析中心的擴張,都促進了市場成長。醫療服務提供者和設備製造商之間的合作,也有助於提高患者獲得治療的機會。

展望未來,穿戴式透析設備和生物相容性膜的創新可望惠及市場。對早期診斷和腎臟預防保健日益重視,可能會影響長期治療策略。開發中國家醫療保險覆蓋範圍的擴大以及對基於遠端醫療的透析監測的投資,將創造新的機會。隨著全球腎臟疾病負擔的加重,透析治療仍將是腎臟疾病管理中不可或缺的一部分。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球血液透析和腹膜透析市場:按類型分類

  • 市場分析、洞察與預測
  • 血液透析
  • 腹膜透析

第5章 全球血液透析及腹膜透析市場:依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 消耗品
  • 服務

第6章 全球血液透析與腹膜透析市場:依最終用途分類

  • 市場分析、洞察與預測
  • 在家工作
  • 醫院基地

第7章 全球血液透析和腹膜透析市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Baxter
    • B. Braun SE
    • Fresenius Medical Care AG
    • Medtronic
    • Asahi Kasei Medical Co. Ltd
    • Nipro Corp
    • DaVita
    • BD
    • Nikkiso Co. Ltd
    • Cantel Medical
簡介目錄
Product Code: VMR112112324

The Hemodialysis & Peritoneal Dialysis Market size is expected to reach USD 315.60 Billion in 2034 from USD 141.06 Billion (2025) growing at a CAGR of 9.36% during 2026-2034.

The Global Hemodialysis & Peritoneal Dialysis Market is expanding due to the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Aging populations, increasing incidence of diabetes and hypertension, and lifestyle-related disorders are major contributors to kidney failure cases. Improved healthcare infrastructure and expanded access to renal replacement therapies are significantly driving market demand.

Technological advancements in dialysis equipment, including portable and home-based systems, are transforming patient care models. Growing preference for home dialysis therapies is reducing hospitalization rates and improving quality of life for patients. Favorable reimbursement policies in developed regions and expanding dialysis centers in emerging economies are supporting market growth. Partnerships between healthcare providers and device manufacturers are enhancing treatment accessibility.

Looking forward, the market is expected to benefit from innovations in wearable dialysis devices and biocompatible membranes. Increasing focus on early diagnosis and preventive nephrology care will influence long-term treatment strategies. Expanding healthcare coverage in developing countries and investments in telehealth-enabled dialysis monitoring will create new opportunities. As kidney disease burden rises globally, dialysis therapies will remain essential in renal care management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Hemodialysis
  • Peritoneal Dialysis

By Product

  • Device
  • Consumables
  • Services

By End-use

  • Home-Based
  • Hospital-Based

COMPANIES PROFILED

  • Baxter, B Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co Ltd, Nipro Corp, DaVita, BD, Nikkiso Co Ltd, Cantel Medical
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Hemodialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Peritoneal Dialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Home-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Hospital-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Product
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Product
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Product
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Product
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Product
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Baxter
    • 9.2.2 B. Braun SE
    • 9.2.3 Fresenius Medical Care AG
    • 9.2.4 Medtronic
    • 9.2.5 Asahi Kasei Medical Co. Ltd
    • 9.2.6 Nipro Corp
    • 9.2.7 DaVita
    • 9.2.8 BD
    • 9.2.9 Nikkiso Co. Ltd
    • 9.2.10 Cantel Medical